Current antibiotic treatments for Clostridioides difficile infection (CDI), which causes the chronic, degenerative disease colitis, eliminate beneficial bacteria in the gut along with the harmful pathogen. Researchers at North Carolina State University (NCSU) have taken the first step toward developing a therapy that attacks C. difficile while sparing other microbes.
Alzheimer’s disease, irritable bowel disease and osteoarthritis place a heavy burden on patients, caregivers and the healthcare system.
Telephone- and web-based cognitive behavioral therapy (CBT) show promise as effective long-term treatments for irritable bowel syndrome (IBS) symptoms, according to a recent study.
Observational studies have linked proton pump inhibitors (PPIs) to a litany of health conditions. A recent randomized controlled trial undermines many of those associations, finding PPIs to be largely safe to use for at least three years.
Gastroenterological conditions pose wide-ranging challenges to researchers and clinicians. Here are some data about this field.
A recent study further explores interrelationships among inflammation, probiotics and mental health.
Researchers in Louisiana have linked GERD with the development of upper aerodigestive tract (UADT) cancers in elderly individuals, but causality remains elusive.
The immunoglobulin E-blocking drug omalizumab limited the risk of adverse effects associated with oral immunotherapy (OIT) and increased OIT’s overall efficacy in participants with multiple food allergies, a phase 2 clinical trial at Stanford University found.
Greater fiber intake may reduce stress by increasing production of short-chain fatty acids (SCFAs), a study by Irish researchers found.
Gut bacteria produce SCFAs, and high-fiber foods stimulate that process, according to a news release about the findings. Feeding...